Meetings: Oversight of Laboratory Developed Tests
Document ID: FDA-2010-N-0274-0001
Comments
Total: 96
-
Paul Valendstein, College of American Pathologists (CAP) - Testimony
Posted : 08/06/2010 ID ：FDA-2010-N-0274-0064 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
Mya Thomae, MyRAQA, Inc. - Testimony
Posted : 08/06/2010 ID ：FDA-2010-N-0274-0065 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
Nancy Wexler - Comment
Posted : 08/06/2010 ID ：FDA-2010-N-0274-0066 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
Sudden Arrhythmia Death Syndromes (SADS) Foundation - Comment
Posted : 08/06/2010 ID ：FDA-2010-N-0274-0067 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
Adele S Schneider, Victor Center for the Prevention of Jewish Genetic Diseases - Testimony
Posted : 08/06/2010 ID ：FDA-2010-N-0274-0068 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
Association of Public Health Laboratories (APHL) - Comment
Posted : 08/06/2010 ID ：FDA-2010-N-0274-0069 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
K. Johnston, MD - Comment
Posted : 08/11/2010 ID ：FDA-2010-N-0274-0070 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
Ombu Enterprises, LLC - Comment
Posted : 08/11/2010 ID ：FDA-2010-N-0274-0071 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
SomaLogic - Comment
Posted : 08/11/2010 ID ：FDA-2010-N-0274-0072 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
Trevor William Rix - Comment
Posted : 08/11/2010 ID ：FDA-2010-N-0274-0073 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
National Coalition for Cancer Survivorship (NCCS) - Comment
Posted : 08/11/2010 ID ：FDA-2010-N-0274-0074 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
American Association of Bioanalysts (AAB) - Comment
Posted : 08/11/2010 ID ：FDA-2010-N-0274-0075 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
Blue Cross Blue Shield Association - Comment
Posted : 08/13/2010 ID ：FDA-2010-N-0274-0076 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
National Health Council - Comment
Posted : 08/13/2010 ID ：FDA-2010-N-0274-0077 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
American Society for Clinical Pathology (ASCP) and The Joint Commission - Comment
Posted : 08/13/2010 ID ：FDA-2010-N-0274-0078 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
Oncimmune USA LLC - Comment
Posted : 08/13/2010 ID ：FDA-2010-N-0274-0079 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
National Society of Genetic Counselors (NSGC) - Comment
Posted : 08/13/2010 ID ：FDA-2010-N-0274-0080 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
The Ohio State University - Comment
Posted : 08/13/2010 ID ：FDA-2010-N-0274-0081 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
Greenwood Genetic Center - Comment
Posted : 08/13/2010 ID ：FDA-2010-N-0274-0082 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
Mayo Clinic - Comment
Posted : 08/13/2010 ID ：FDA-2010-N-0274-0083 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
Hannah Wernke Memorial Foundation - Comment
Posted : 08/17/2010 ID ：FDA-2010-N-0274-0084 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
Perry Renshaw - Comment
Posted : 08/17/2010 ID ：FDA-2010-N-0274-0085 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
College of American Pathologists (CAP) - Comment
Posted : 08/17/2010 ID ：FDA-2010-N-0274-0086 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
Howard C Wetsman - Comment
Posted : 08/17/2010 ID ：FDA-2010-N-0274-0087 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
Biotechnology Industry Organization (BIO) - Comment
Posted : 08/17/2010 ID ：FDA-2010-N-0274-0088 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
Stephanie Hallam - Comment
Posted : 08/17/2010 ID ：FDA-2010-N-0274-0089 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
Small Biotechnology Business Coalition - Comment
Posted : 08/17/2010 ID ：FDA-2010-N-0274-0090 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
Georgirene D. Vladutiu - Testimony
Posted : 08/17/2010 ID ：FDA-2010-N-0274-0091 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
Katherine Borges - Testimony
Posted : 08/17/2010 ID ：FDA-2010-N-0274-0092 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
Longwell and Associates - Comment
Posted : 08/17/2010 ID ：FDA-2010-N-0274-0093 Agency : FDA -
Aug 15,2010 11:59 PM ET